Abstract | OBJECTIVE: DATA SOURCES: English-language clinical studies, abstracts, and review articles identified from MEDLINE searches and bibliographies of identified articles. Unpublished data were obtained from the Food and Drug Administration in accordance with the Freedom of Information Act. STUDY SELECTION: DATA EXTRACTION: Pertinent studies were selected and the data were synthesized into a review format. DATA SYNTHESIS: CONCLUSIONS:
|
Authors | I Hsu, S A Spinler, N E Johnson |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
1995 Jul-Aug
Vol. 29
Issue 7-8
Pg. 743-59
ISSN: 1060-0280 [Print] United States |
PMID | 8520093
(Publication Type: Comparative Study, Journal Article, Review)
|
Chemical References |
- Anticholesteremic Agents
- Enzyme Inhibitors
- Fatty Acids, Monounsaturated
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Indoles
- Fluvastatin
- Lovastatin
- Simvastatin
- Pravastatin
|
Topics |
- Anticholesteremic Agents
(adverse effects, pharmacology, therapeutic use)
- Cataract
(chemically induced)
- Clinical Trials as Topic
- Economics, Pharmaceutical
- Enzyme Inhibitors
(adverse effects, pharmacology, therapeutic use)
- Fatty Acids, Monounsaturated
(adverse effects, pharmacology, therapeutic use)
- Fluvastatin
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hypercholesterolemia
(drug therapy)
- Indoles
(adverse effects, pharmacology, therapeutic use)
- Lovastatin
(adverse effects, analogs & derivatives, pharmacology, therapeutic use)
- Pravastatin
(adverse effects, pharmacology, therapeutic use)
- Simvastatin
|